| CLIN |
PATH |
DEFINITIONS |
| |
|
PRIMARY TUMOR
(PT) |
|
|
|
pTX |
Primary
tumor cannot be assessed |
|
|
|
pT0 |
No
evidence of primary tumor |
|
|
|
pTis |
Melanoma
in situ (atypical melanocytic hyperplasia, severe
melanocytic dysplasia, not an invasive lesion
(Clark's Level I) |
|
|
|
pT1 |
Tumor
0.75 mm or less in thickness and invades the
papillary dermis (Clark's Level II) |
|
|
|
pT2 |
Tumor
more than 0.75 mm but not more than 1.5 mm in
thickness and/or invades to papillary-reticular
dermal interface (Clark's Level III) |
|
|
|
pT3 |
Tumor
more than 1.5 mm but not more than 4 mm in
thickness and/or invades the reticular dermis
(Clark's V)Level I |
|
|
|
|
pT3a
|
Tumor
more than 1.5 mm but not more than 3 mm in
thickness |
|
|
|
|
pT3b
|
Tumor
more than 3 mm but not more than 4 mm in
thickness |
|
|
|
pT4 |
Tumor
more than 4 mm in thickness and/or invades the
subcutaneous tissue (Clark's Level V) and/or
satellite(s) within 2 cm of the primary tumor |
|
|
|
|
pT4a
|
Tumor
more than 4 mm in thickness and/or invades the
subcutaneous tissue |
|
|
|
|
pT4b
|
Satellite(s)
within 2 cm of primary tumor |
| |
|
LYMPH NODE (N) |
|
|
|
NX |
Regional
lymph nodes cannot be assessed |
|
|
|
N0 |
No
regional lymph node metastasis |
|
|
|
N1 |
Metastasis
3 cm or less in greatest dimension in any
regional lymph node(s) |
|
|
|
N2 |
Metastasis
more than 3 cm in greatest dimension in any
regional lymph node(s) and/or in-transit
metastasis |
|
|
|
|
N2a
|
Metastasis
more than 3 cm in greatest dimension in any
regional lymph node(s) |
|
|
|
|
N2b
|
In-transit
metastasis |
|
|
|
|
N2c
|
Both
(N2a and N2b) |
| |
|
DISTANT METASTASIS (M) |
|
|
|
MX |
Presence
of distant metastasis cannot be assessed |
|
|
|
M0 |
No
distant metastasis |
|
|
|
M1 |
Distant
metastasis |
|
|
|
M1a |
|
Metastasis
in skin or subcutaneous tissue or lymph node(s)
beyond the regional lymph nodes |
|
|
|
M1b |
|
Visceral
metastasis |